Error: Could not add to watchlist. X

DekaLux-BioTech

+ Watchlist
DKXBITF:LX
488.65
EUR
4.67
0.96%
As of 00:59:30 ET on 06/29/2015.
Volume
0
Previous Close
483.98
52Wk Range
266.42 - 500.95
1 Yr Return
75.26%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/29/2015)
488.65
Total Assets (m EUR) (on 06/29/2015)
349.260
Inception Date
06/02/2008
Last Dividend (on 06/30/2014)
-
Dividend Indicated Gross Yield
-
Fund Managers
ROGER VOGT
Front Load Fee
0.00%
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
1.25%
Expense Ratio
2.19%
Top Fund Holdings
Name Position Value % of Fund
Celgene Corp 206.18 k 19.39 m 7.16
Amgen Inc 140.56 k 18.80 m 6.95
Regeneron Pharmaceuticals Inc 48.59 k 16.52 m 6.10
Biogen Inc 57.11 k 16.11 m 5.95
Gilead Sciences Inc 182.10 k 14.55 m 5.38
Vertex Pharmaceuticals Inc 104.70 k 10.30 m 3.81
Mylan NV 200.50 k 9.50 m 3.51
Alexion Pharmaceuticals Inc 57.86 k 8.97 m 3.31
Illumina Inc 54.61 k 8.50 m 3.14
BioMarin Pharmaceutical Inc 78.85 k 5.97 m 2.21
Profile
DekaLux-BioTech is an open-end fund incorporated in Luxembourg. The objective is growth. The Fund invests in equity securities worldwide, that are issued by companies involved in the discovery, research, development, production, distribution, and marketing of biotechnological products for medical applications.
ADDRESS
Deka International SA
5, rue des Labours
L-1912 Luxembourg
Luxembourg
PHONE
352-3409-39 Tel
WEBSITE
-